Predictive factors for recurrent disease (bivariate and multivariable logistic regression analysis) in patients with non-serous tumors.

<p>Predictive factors for recurrent disease (bivariate and multivariable logistic regression analysis) in patients with non-serous tumors.</p

Serous ovarian carcinoma with nuclear positivity for HRNPM (brown staining).

<p>Serous ovarian carcinoma with nuclear positivity for HRNPM (brown staining).</p

The 5-year disease-free survival for the subgroup of patients with SLC1A5 positivity of tumors was 92% compared with the 5-year DFS (disease-free survival) of 66% for the subgroup of patients with SLC1A5 negativity of tumors.

<p>The 5-year disease-free survival for the subgroup of patients with SLC1A5 positivity of tumors was 92% compared with the 5-year DFS (disease-free survival) of 66% for the subgroup of patients with SLC1A5 negativity of tumors.</p

Protein expression of apoptosis and angiogenesis regulators versus SLC1A5 status in ovarian tumors (n = 121).

<p>Protein expression of apoptosis and angiogenesis regulators versus SLC1A5 status in ovarian tumors (n = 121).</p